Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs Allopurinol for Cardiovascular Risk in Gout (FORWARD)
NCT02500641Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Aug 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 4 trial of febuxostat in gout, sponsored by Menarini Group. Started Aug 2015; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT02500641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500641.